You searched for bevacizumab - MPR

Your search for bevacizumab returned 10 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Da Hee Han, PharmD remove

Your search for bevacizumab returned 10 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Cancer Peptide Vaccine Designated Orphan Drug for MDS

Data from a Phase 1/2 study in patients with MDS who had disease progression on or after first-line azacitidine treatment showed initial signs of clinical activity with DSP-7888, and that it was well tolerated in study patients.
News

Ophthalmic Txs for DME Compared in NIH-Funded Study

Treatment with Eylea (aflibercept; Regeneron) led to greater average visual improvement than Avastin (bevacizumab; Genentech) or Lucentis (ranibizumab; Genentech) when vision was 20/50 or worse at treatment initiation, but similar improvement when the starting vision was 20/40-20/32, data from a clinical trial has shown.
News

FDA Approves Avastin for Platinum-Sensitive Recurrent Ovarian Cancer

Genentech announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine, followed by Avastin alone, for the treatment of patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.